Image Courtesy of Retail Pharmacy Magazine Democrats are up in arms, accusing President Trump and the Department of Government Efficiency (DOGE) of gutting drug research funding. Social media is flooded with dramatic claims—photos of sick children, stories of desperate patients—each suggesting that Trump has cut off their last hope. The truth, however, is far less dramatic. The Trump administration has indeed pushed aggressive cost-cutting across federal agencies, including the National Institutes of Health (NIH), which funds a large share of America’s drug research. But contrary to the headlines, there’s no blanket halt on medical research—far from it. Studies continue under other federal programs and through robust private funding, supporting everything from cancer breakthroughs to rare disease therapies. What the administration has done is implement targeted…
Click here to read the full article at The Gateway Pundit.
